Neoclarityn Disease Interactions
There are 2 disease interactions with Neoclarityn (desloratadine).
Desloratadine (applies to Neoclarityn) asthma
Moderate Potential Hazard, Moderate plausibility.
Desloratadine products contain sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. Caution is advised when using these products in people with asthma.
References
- (2002) "Product Information. Clarinex (desloratadine)." Schering Corporation
Desloratadine (applies to Neoclarityn) renal/hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
Dosing adjustment of desloratadine is recommended for patients with renal or hepatic impairment. Dosing recommendations for children with liver or renal impairment cannot be made due to lack of data.
References
- (2002) "Product Information. Clarinex (desloratadine)." Schering Corporation
Neoclarityn drug interactions
There are 20 drug interactions with Neoclarityn (desloratadine).
More about Neoclarityn (desloratadine)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antihistamines
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.